Access to anti-retroviral drugs, female in Djibouti
Djibouti: Access to anti-retroviral drugs, female was 23.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, female in Djibouti, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, female in Djibouti is 23.0%, measured in 2024.
Compared with earlier readings it is down 17.9% on the previous year and up 43.8% over ten years.
Over the whole period, access to anti-retroviral drugs, female in Djibouti peaked at 32.0% in 2018 and was at its lowest, 0.0%, in 2000.
Djibouti ranks 137th of 141 countries on this measure, in the bottom quarter.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, female in Djibouti, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2004 | 1.0% | — |
| 2005 | 2.0% | +100.0% |
| 2006 | 4.0% | +100.0% |
| 2007 | 5.0% | +25.0% |
| 2008 | 6.0% | +20.0% |
| 2009 | 7.0% | +16.7% |
| 2010 | 8.0% | +14.3% |
| 2011 | 9.0% | +12.5% |
| 2012 | 11.0% | +22.2% |
| 2013 | 12.0% | +9.1% |
| 2014 | 16.0% | +33.3% |
| 2015 | 18.0% | +12.5% |
| 2016 | 22.0% | +22.2% |
| 2017 | 28.0% | +27.3% |
| 2018 | 32.0% | +14.3% |
| 2019 | 21.0% | -34.4% |
| 2020 | 23.0% | +9.5% |
| 2021 | 21.0% | -8.7% |
| 2022 | 24.0% | +14.3% |
| 2023 | 28.0% | +16.7% |
| 2024 | 23.0% | -17.9% |
Djibouti compared with similar countries
- Djibouti's 23.0% is below the median for lower middle income countries, which is 80.0%, 29% of the median. (39 countries reporting)
- Djibouti's 23.0% is below the median for Middle East, North Africa, Afghanistan & Pakistan, which is 55.0%, 42% of the median. (20 countries reporting)
Biggest year-on-year movements
Years where Access to anti-retroviral drugs, female in Djibouti changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2005 | +100.0% | 1.0% | 2.0% |
| 2006 | +100.0% | 2.0% | 4.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 2.8% | 0.0% | 7.0% | 9 |
| 2010s | 17.7% | 8.0% | 32.0% | 10 |
| 2020s | 23.8% | 21.0% | 28.0% | 5 |
Countries ranked near Djibouti
More gender data for Djibouti
- Child population (UN estimates and projections) 344.48 (2030)
- Child population (UN estimates and projections) (0-14), annual growth 0.3133 % change on previous year (2030)
- Population 918.2 (2030)
- Working-age population (UN estimates and projections) 918.2 (2030)
- Population (UN estimates and projections), annual growth rate 1.65 % change on previous year (2030)
- Age population, age 00, female, interpolated 11,687 (2025)
- Age population, age 00, male, interpolated 12,048 (2025)
- Age population, age 01, female, interpolated 11,479 (2025)
- Age population, age 01, male, interpolated 11,814 (2025)
- Age population, age 02, female, interpolated 11,302 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in Djibouti?
- Access to anti-retroviral drugs, female in Djibouti was 23.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in Djibouti?
- The highest recorded value was 32.0% in 2018.
- What is the lowest access to anti-retroviral drugs, female recorded in Djibouti?
- The lowest recorded value was 0.0% in 2000.
- How does Djibouti rank for access to anti-retroviral drugs, female?
- Djibouti ranks 137th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, female rising or falling in Djibouti?
- Over the last ten years it is up 43.8%. The long-run trend across the full record is volatile.
- Where does this Djibouti data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 24 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.